TTrialPathMatch Me to Trials
← Back to trials
RecruitingEndometriosisAdenomyosis

Clinical and Molecular Study of Endometriosis and Adenomyosis

Eligible age

18–42 yrs

Accepts

Women

Locations

0 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

The purpose of this study is to determine whether endometriosis and adenomyosis are progressive diseases, in terms of symptoms (pain, abnormal uterine bleeding and infertility), anatomical lesions size, and recurrences. We also aimed to address molecular questions on immune dialogues between ectopic lesions and the eutopic endometrium, auto-immunity in endometriosis and adenomyosis and the role of the microbiota in their respective pathophysiologies.

Sponsor: Assistance Publique - Hôpitaux de Paris

You may qualify if…

  • ✓ Women of age between - 18 and 42 years old.
  • ✓ In-service care for one of the pelvic pain and/or infertility, or for a pelvic mass.
  • ✓ Having a radiological diagnosis made by a referral practitioner and/or operated in the department

You may not qualify if…

  • ✕ HIV-positive women, HBV and HCV
  • ✕ During pregnancy
  • ✕ Having a cancer diagnosis
  • ✕ Refusing to sign a consent.

Source: ClinicalTrials.gov · NCT04481321 · last updated 2025-11-20

Clinical and Molecular Study of Endometriosis and Adenomyosis · TrialPath